September 08, 2020
Texas Tech University Health Sciences Center Faculty Supporting Regeneron Trial
Texas Tech University Health Sciences Center (TTUHSC) faculty from Amarillo have engaged in a professional services agreement with PharmaTex Research, a multi-specialty clinical research group that conducts clinical trials required by the FDA, in a study of REGN-COV2, Regeneron’s novel anti-viral antibody
cocktail that is being studied for its potential to treat people with COVID-19 and to prevent SARS-CoV-2 infection.